GlassScriptPhysician profile
Blake Mcneill Hodges
NPI 1659710440
$8,530.38
in general payments reported to CMS, 2019-2025
59 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $712 · 2021: $1,163 · 2022: $1,228 · 2023: $1,422 · 2024: $1,622 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,853.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $842.01 | 2020-2025 | |
| Amgen INC. | $692.86 | 2019-2025 | Repatha, Evenity, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $650.50 | 2019-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $586.04 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $502.63 | 2020-2025 | Rexulti, Nuedexta |
| Lundbeck LLC | $467.06 | 2022-2025 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $441.12 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novartis Pharmaceuticals Corporation | $346.02 | 2019-2025 | |
| Argenx US, INC. | $336.09 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $314.71 | 2021-2025 | |
| Ucb, INC. | $275.68 | 2024-2025 | Rystiggo, Fintepla |
| Abbott Laboratories | $264.05 | 2019-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Takeda Pharmaceuticals U.S.A., INC. | $253.34 | 2021-2025 | Hyqvia, Trintellix |
| Lilly USA, LLC | $225.88 | 2021-2025 | Jardiance, Mounjaro, Kisunla |
| Eisai INC. | $188.81 | 2021-2025 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.